Search for other papers by Florian Schederecker in
Google Scholar
PubMed
Search for other papers by Alexander Cecil in
Google Scholar
PubMed
Search for other papers by Cornelia Prehn in
Google Scholar
PubMed
Search for other papers by Jana Nano in
Google Scholar
PubMed
Deutsches Herzzentrum München, Technische Universität München, DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
Search for other papers by Wolfgang Koenig in
Google Scholar
PubMed
Lehrstuhl für Experimentelle Genetik, Technische Universität München, Freising-Weihenstephan, Germany
Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Search for other papers by Jerzy Adamski in
Google Scholar
PubMed
German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Germany
Search for other papers by Tanja Zeller in
Google Scholar
PubMed
German Centre for Cardiovascular Research (DZHK), Partner Site Munich, Munich, Germany
Search for other papers by Annette Peters in
Google Scholar
PubMed
Search for other papers by Barbara Thorand in
Google Scholar
PubMed
binding globulin (SHBG) is a binding protein with high binding affinity for dihydrotestosterone (DHT), testosterone and estradiol (E2), and SHBG regulates their biological availability in the circulation ( 11 ). SHBG has been shown to be positively
Department of Pediatrics, Federal University of Uberlandia (UFU), Uberlandia, Minas Gerais, Brazil
Search for other papers by Letícia Ribeiro Oliveira in
Google Scholar
PubMed
Search for other papers by Carlos Alberto Longui in
Google Scholar
PubMed
Department of Pediatrics, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil
Search for other papers by Guilherme Guaragna-Filho in
Google Scholar
PubMed
Poison Control Center, FCM, UNICAMP, Campinas, Sao Paulo, Brazil
Search for other papers by José Luiz Costa in
Google Scholar
PubMed
Search for other papers by Rafael Lanaro in
Google Scholar
PubMed
Search for other papers by David Antônio Silva in
Google Scholar
PubMed
Search for other papers by Maria Izabel Chiamolera in
Google Scholar
PubMed
Laboratory of Human Molecular Genetics, Center for Molecular Biology and Genetics Engineering (CBMEG), UNICAMP, Campinas, Sao Paulo, Brazil
Search for other papers by Maricilda Palandi de Mello in
Google Scholar
PubMed
Search for other papers by André Moreno Morcillo in
Google Scholar
PubMed
Department of Medical Genetics and Genomic Medicine, FCM, UNICAMP, Campinas, Sao Paulo, Brazil
Search for other papers by Andrea Trevas Maciel-Guerra in
Google Scholar
PubMed
Department of Pediatrics, FCM, UNICAMP, Campinas, Sao Paulo, Brazil
Search for other papers by Gil Guerra-Junior in
Google Scholar
PubMed
subcutaneously by the main investigator of the study. IA data Hormones assessed at the two moments of the study were total testosterone, dihydrotestosterone (DHT), dehydroepiandrosterone (DHEA) and androstenedione. Each one was evaluated by IA and LC
Search for other papers by I Savchuk in
Google Scholar
PubMed
Search for other papers by M L Morvan in
Google Scholar
PubMed
Search for other papers by J P Antignac in
Google Scholar
PubMed
Search for other papers by K Gemzell-Danielsson in
Google Scholar
PubMed
Search for other papers by B Le Bizec in
Google Scholar
PubMed
Search for other papers by O Söder in
Google Scholar
PubMed
Search for other papers by K Svechnikov in
Google Scholar
PubMed
known that testosterone can be further converted to 5α-dihydrotestosterone (DHT) in the target tissue such as the external genital tissue ( 7 ), and this metabolic process from cholesterol to DHT by means of testosterone is called the conventional
Sahlgrenska Osteoporosis Centre, Center for Bone and Arthritis Research (CBAR), Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Henrik Ryberg in
Google Scholar
PubMed
Sahlgrenska Osteoporosis Centre, Center for Bone and Arthritis Research (CBAR), Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Anna-Karin Norlén in
Google Scholar
PubMed
Sahlgrenska Osteoporosis Centre, Center for Bone and Arthritis Research (CBAR), Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Andreas Landin in
Google Scholar
PubMed
Search for other papers by Per Johansson in
Google Scholar
PubMed
Search for other papers by Zeinab Salman in
Google Scholar
PubMed
Search for other papers by Anders Wallin in
Google Scholar
PubMed
Department of Endocrinology, Skaraborg Central Hospital, Skövde, Sweden
Search for other papers by Johan Svensson in
Google Scholar
PubMed
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
estrogens E1 and E2. In addition, testosterone can be metabolized to the highly potent androgen DHT by 5α-reductase ( 1 , 5 ). However, a more comprehensive description of the complex metabolism of steroids in the brain can be found elsewhere ( 6 ). Sex
Search for other papers by Hong Tang in
Google Scholar
PubMed
Search for other papers by Xiaomei Jiang in
Google Scholar
PubMed
Search for other papers by Yu Hua in
Google Scholar
PubMed
Search for other papers by Heyue Li in
Google Scholar
PubMed
Search for other papers by Chunlan Zhu in
Google Scholar
PubMed
Search for other papers by Xiaobai Hao in
Google Scholar
PubMed
Search for other papers by Minhui Yi in
Google Scholar
PubMed
Search for other papers by Linxia Li in
Google Scholar
PubMed
, and 100 μg/mL streptomycin. For in vitro cell model, KGN cells were treated with dihydrotestosterone (DHT) 500 nM for 24 h. Cell counting kit-8 assay KGN cell viability was analyzed by Cell counting kit-8 (CCK-8) assay (Abcam) according to
Department of Medicine-Western Health, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia
Search for other papers by Alexander Tacey in
Google Scholar
PubMed
Institute for Physical Activity and Nutrition, Deakin University, Geelong, Victoria, Australia
Search for other papers by Lewan Parker in
Google Scholar
PubMed
Search for other papers by Bu B Yeap in
Google Scholar
PubMed
Search for other papers by John Joseph in
Google Scholar
PubMed
Search for other papers by Ee M Lim in
Google Scholar
PubMed
Search for other papers by Andrew Garnham in
Google Scholar
PubMed
Search for other papers by David L Hare in
Google Scholar
PubMed
Search for other papers by Tara Brennan-Speranza in
Google Scholar
PubMed
Department of Medicine-Western Health, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia
Search for other papers by Itamar Levinger in
Google Scholar
PubMed
, Australia). White blood cell (WBC) counts, red blood cell (RBC) counts, haemoglobin and haematocrit concentrations were analysed with a Sysmex KX – 21N (Kobe, Japan). Serum testosterone and dihydrotestosterone (DHT) were measured by liquid chromatography
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Search for other papers by Satoshi Inoue in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Search for other papers by Taichi Mizushima in
Google Scholar
PubMed
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Search for other papers by Hiroki Ide in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Guiyang Jiang in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Takuro Goto in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Yujiro Nagata in
Google Scholar
PubMed
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA
Search for other papers by George J Netto in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Department of Urology, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Hiroshi Miyamoto in
Google Scholar
PubMed
dihydrotestosterone (DHT), especially in the presence of epidermal growth factor (EGF), could activate the EGF receptor (EGFR)/ERBB2/ERK pathway in AR-positive bladder cancer cells ( 8 ). We therefore anticipated that AR signals in bladder cancer cells contributed to
Search for other papers by Estelle Bonnet in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de psychopathologie du développement, Bron, France
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Centre de biologie et pathologie Est, Service d’hormonologie, d’endocrinologie moléculaire et des maladies rares, Bron, France
Search for other papers by Mathias Winter in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Centre de biologie et pathologie Est, Service d’hormonologie, d’endocrinologie moléculaire et des maladies rares, Bron, France
Search for other papers by Delphine Mallet in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service Endocrinologie Moléculaire et Maladies Rares, Bron, France
Search for other papers by Ingrid Plotton in
Google Scholar
PubMed
Search for other papers by Claire Bouvattier in
Google Scholar
PubMed
Search for other papers by Maryse Cartigny in
Google Scholar
PubMed
Search for other papers by Laetiti Martinerie in
Google Scholar
PubMed
Search for other papers by Michel Polak in
Google Scholar
PubMed
Search for other papers by Anne Bachelot in
Google Scholar
PubMed
Search for other papers by Frédéric Huet in
Google Scholar
PubMed
Search for other papers by Sabine Baron in
Google Scholar
PubMed
Search for other papers by Muriel Houang in
Google Scholar
PubMed
Search for other papers by Sylvie Soskin in
Google Scholar
PubMed
Search for other papers by Anne Lienhardt in
Google Scholar
PubMed
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed
Search for other papers by Cyril Amouroux in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de chirurgie Uro-viscérale et de Transplantation de l’Enfant, Bron, France
Search for other papers by Aurore Bouty in
Google Scholar
PubMed
Search for other papers by Lise Duranteau in
Google Scholar
PubMed
Search for other papers by Rémi Besson in
Google Scholar
PubMed
Search for other papers by Alaa El Ghoneimi in
Google Scholar
PubMed
Search for other papers by Dinane Samara-Boustani in
Google Scholar
PubMed
Search for other papers by François Becmeur in
Google Scholar
PubMed
Search for other papers by Nicolas Kalfa in
Google Scholar
PubMed
Search for other papers by Françoise Paris in
Google Scholar
PubMed
Search for other papers by François Medjkane in
Google Scholar
PubMed
Hospices Civils de Lyon, Groupement Hospitalier Est, Service d’endocrinologie, Bron, France
Search for other papers by Aude Brac de la Perrière in
Google Scholar
PubMed
Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
Search for other papers by Patricia Bretones in
Google Scholar
PubMed
Université Claude Bernard, Lyon, France
Search for other papers by Hervé Lejeune in
Google Scholar
PubMed
Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
Université Claude Bernard, Lyon, France
Search for other papers by Marc Nicolino in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de chirurgie Uro-viscérale et de Transplantation de l’Enfant, Bron, France
Université Claude Bernard, Lyon, France
Search for other papers by Pierre Mouriquand in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de chirurgie Uro-viscérale et de Transplantation de l’Enfant, Bron, France
Search for other papers by Daniela-Brindusa Gorduza in
Google Scholar
PubMed
Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
Search for other papers by Claire-Lise Gay in
Google Scholar
PubMed
with or without clitoromegaly to hypospadias and micropenis. Both conditions are characterized by a marked virilization at puberty, as other enzymatic mechanisms allow complete steroidogenesis up to dihydrotestosterone (DHT) ( 1 , 7 , 8 ). Hence, they
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Annette Mouritsen in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Alexander Siegfried Busch in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Lise Aksglaede in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Ewa Rajpert-De Meyts in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
Estradiol (E2) and dihydrotestosterone (DHT). Finally, T concentration depends on the clearance rate, determined by, conversion of T to its metabolites, conjugation capacity, as well as urinary excretion. The ability of excreting T and other steroids in the
Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.
Search for other papers by Angelica Lindén Hirschberg in
Google Scholar
PubMed
. Virilization may proceed at puberty. Possibly Deficiency of the enzyme 5α-reductase type 2, a very rare autosomal recessive condition caused by mutation in the SRD5A2 gene, results in failure to convert testosterone into dihydrotestosterone (DHT